Management of pregnancy in women with pulmonary hypertension secondary to SLE and anti-phospholipid syndrome

Abstract

Pulmonary hypertension is found in about 10% of patients with systemic lupus erythematosis (SLE). Pulmonary hypertension may be present at the time of diagnosis or may develop after the diagnosis of SLE or anti-phospholipid syndrome (APS). It often presents in the reproductive years and has a significant impact on pregnancy outcome, being a significant cause of indirect maternal deaths. In our observationalcase series of three patients there were two deaths (66%). In cases 1 and 2 the pulmonary hypertension developed during pregnancy and deteriorated rapidly with markedly abnormal mean pulmonary artery pressures of 80 and 70 mmHg respectively prior to death. Both patients died within 48 hours of delivery. In case 3 the pulmonary hypertensionwas milder and was diagnosed very early in pregnancy. The patient received multidisciplinary care from the first trimester and the management of the pregnancy, delivery and the early puerperium was planned. Careful epidural anaesthesia was used and the patient had invasive monitoring on the intensive therapy unit (ITU) for 72 hours. Women with pulmonary hypertensionneed to be aware of the high risk of maternal mortality associated with pregnancy but we believe that an improvement in outcome can be achieved by careful assessment and the use of a multidisciplinary approach from early in pregnancy.

Keywords

anti-phospholipid syndrome lupus pregnancy pulmonary hypertension therapy

Get full access to this article

View all access options for this article.

References

Rubin LJ . Primary pulmonary hypertension . Chest 1993; 104: 236–250 .

Quismorio FP Jr , Sharma O , Koss M et al. Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus . Semin Arthritis Rheum 1984; 13: 349–359 .

Asherson RA , Higenbottam TW , Dinh Xuan AT , Khamashta MA , Hughes GR . Pulmonary hypertension in a lupus clinic: experience with twenty-four patients . J Rheumatol 1990; 17: 1292–1298 .

Asherson RA , Oakley CM . Pulmonary hypertension and systemic lupus erythematosus . J Rheumatol 1986; 13: 1–5 .

Gurubhagavatula I , Palevsky HI . Pulmonary hypertension in systemic autoimmune disease . Rheum Dis Clin North Am 1997; 23: 365–394 .

Asherson RA , Mackworth-Young CG , Boey ML et al. Pulmonary hypertension in systemic lupus erythematosus . Br Med J 1983; 287: 1024–1025 .

Asherson RA , Cervera R . Review: antiphospholipid antibodies and the lung . J Rheumatol 1995; 22: 62–66 .

Horn CA . Pulmonary hypertension and autoimmune disease . Chest 1993; 104: 279–280 .

Connolly HM , Crary JL , McGoon MD et al. Valvular heart disease associated with fenfluramine-phentermine . New Engl J Med 1997; 337: 581–588 .

10.

Gertner E . Diffuse alveolar hemorrhage in the antiphospholipid syndrome: spectrum of disease and treatment . J Rheumatol 1999; 26: 805–807 .

11.

Weiss BM , Zemp L , Seifert B , Hess OM . Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996 . J Am Coll Cardiol 1998; 31: 1650–1657 .

12.

Asherson RA . Pulmonary hypertension in systemic lupus erythematosus . J Rheumatol 1990; 17: 414–415 .

13.

Winslow TM , Ossipov MA , Fazio GP , Simonson JS , Redberg RF , Schiller NB . Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus . Am Heart J 1995; 129: 510–515 .

14.

DHSS . Confidential enquiries in to maternal deaths in the United Kingdom (1997–1999) . Royal College of Obstetricians and Gynaecologists, 2001 (ISBN 1-900364- 65-64).

15.

Rubin LJ . Approach to the diagnosis and treatment of pulmonary hypertension . Chest 1989; 96: 659–664 .

16.

Smedstad KG , Cramb R , Morison DH . Pulmonary hypertension and pregnancy: a series of eight cases . Can J Anaesth 1994; 41: 502–512 .

17.

Badalian SS , Silverman RK , Aubry RH , Longo J . Twin pregnancy in a woman on long-term epoprostenol therapy for primary pulmonary hypertension. A case report . J Reprod Med 2000; 45: 149–152 .

18.

O'Hare R , McLoughlin C , Milligan K , McNamee D , Sidhu H . Anaesthesia for caesarean section in the presence of severe primary pulmonary hypertension . Br J Anaesth 1998; 81: 790–792 .

19.

Olschewski H , Walmrath D , Schermuly R , Ghofrani A , Grimminger F , Seeger W . Aerosolized prostacyclin and iloprost in severe pulmonary hypertension . Ann Intern Med 1996; 124: 820–824 .

20.

Mikhail G , Gibbs J , Richardson M et al. An evaluation of nebulized prostacyclin in patients with primary and secondary pulmonary hypertension . Eur Heart J 1997; 18: 1499–1504 .

21.

Gaine SP , Rubin LJ . Primary pulmonary hypertension . Lancet 1998; 352: 719–725 .

22.

Martinez JM , Comas C , Sala X , Gratacos E , Torres PJ , Fortuny A . Maternal primary pulmonary hypertension associated with pregnancy . Eur J Obstet Gynecol Reprod Biol 1994; 54: 143–147 .